Bladder Cancer Therapeutics Market to Reach US$ 456.3 Mn by 2034 Amid Advancements in Immunotherapy and Targeted Treatments
The global industry was valued at US$ 271.4 Mn in 2023 and is expected to grow at a CAGR of 4.8% from 2024 to 2034, reaching US$ 456.3 Mn by the end of 2034. The bladder cancer therapeutics market is steadily evolving as advancements in oncology research, particularly in immunotherapy and targeted drug development, reshape treatment paradigms. Increasing prevalence of bladder cancer, especially...
0 Comments 0 Shares 84 Views 0 Reviews
Sponsored